IRIS
GIANCANE, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.914
Totale 2.914
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.914
Totale 2.914
Salva come PNG Salva come JPEG
Città #
Genova 1.907
Rapallo 377
Genoa 314
Vado Ligure 311
Bordighera 5
Totale 2.914
Salva come PNG Salva come JPEG
Nome #
Juvenile Idiopathic Arthritis: Diagnosis and Treatment 161
Agreement among musculoskeletal pediatric specialists in the assessment of radiographic joint damage in juvenile idiopathic arthritis. 145
Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases 129
Pharmacovigilance in juvenile idiopathic arthritis patients (pharmachild) treated with biologic agents and/or methotrexate. A Pediatric Rheumatology International Trials Organisation (PRINTO)/Pediatric Rheumatology European Society (PRES) registry 121
Clinical outcome measures in juvenile idiopathic arthritis 117
IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis 115
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries 115
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis 112
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study 109
Recent therapeutic advances in juvenile idiopathic arthritis 106
Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis. 105
Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever 101
EULAR recommendations for the management of familial Mediterranean fever 99
Temporomandibular joint involvement in juvenile idiopathic arthritis: Reliability and validity of a screening protocol for the rheumatologist 98
Disease activity and damage in juvenile idiopathic arthritis: Methotrexate era versus biologic era 98
Primary hypertrophic osteoarthropathy: An update on patient features and treatment 98
Update on the pathogenesis and treatment of juvenile idiopathic arthritis 96
A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis 95
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients 93
Treatment of juvenile idiopathic arthritis: what's new? 90
Paediatric rheumatic disease: What is the best definition of clinical remission in JIA? 89
Information technology in paediatric rheumatology 73
Determinants of discordance between criteria for inactive disease and low disease activity in juvenile idiopathic arhritis 70
Temporomandibular Joint Involvement is Associated with Quality of Life, Disability and High Disease Activity in Juvenile Idiopathic Arthritis 68
Open issues in the assessment and management of pain in juvenile idiopathic arthritis 66
Growth and puberty in juvenile dermatomyositis: a longitudinal cohort study 62
Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis 62
The Effect of Morning Stiffness Duration on the Definition of Clinically Inactive Disease in Juvenile Idiopathic Arthritis 59
A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis 58
Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee 51
Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: Post hoc radiographic analysis from two randomized controlled trials 48
Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis 41
A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis 37
Outcome Scores in Pediatric Rheumatology 31
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 22
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study 8
Totale 3.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.393
article - articoli 11.126
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.519
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020671 0 0 0 0 0 109 141 87 88 138 82 26
2020/2021460 19 47 16 43 12 28 85 32 37 52 41 48
2021/2022411 16 12 18 32 15 40 15 81 43 52 20 67
2022/2023442 36 42 8 41 87 61 1 39 72 2 48 5
2023/2024257 18 36 4 40 22 19 19 15 16 13 10 45
2024/2025316 32 52 35 60 74 63 0 0 0 0 0 0
Totale 3.048